MNRI and Fetal Alcohol Spectrum Disorders: Function and Quality of Life
- Jun 21
- 1 min read
This study explored the effects of MNRI® in children ages 1–13 with fetal alcohol spectrum disorders (FASD). Researchers observed improvements in reflex patterns, coordination, behavior, sleep, and caregiver engagement following two rehabilitation sessions. The findings suggest that MNRI may support psychomotor development and overall functioning, highlighting its potential as a complementary approach for addressing neurodevelopmental challenges associated with FASD.